Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Gyre Therapeutics, Inc.
IPO Date: August 21, 2015
Sector: Healthcare
Industry: Biotech
Market Cap: $649.1M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.29 | 3.85%
Avg Daily Range (30 D): $0.23 | 2.91%
Avg Daily Range (90 D): $0.43 | 4.84%
Institutional Daily Volume
Avg Daily Volume: .43M
Avg Daily Volume (30 D): .12M
Avg Daily Volume (90 D): .18M
Trade Size
Avg Trade Size (Sh.): 244
Avg Trade Size (Sh.) (30 D): 65
Avg Trade Size (Sh.) (90 D): 71
Institutional Trades
Total Inst.Trades: 120
Avg Inst. Trade: $1.59M
Avg Inst. Trade (30 D): $1.63M
Avg Inst. Trade (90 D): $1.45M
Avg Inst. Trade Volume: .46M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.83M
Avg Closing Trade (30 D): $3.74M
Avg Closing Trade (90 D): $1.85M
Avg Closing Volume: 584.83K
   
News
Jun 10, 2025 @ 11:00 AM
Gyre Therapeutics Announces First Dosing in Phase ...
Source: N/A
May 23, 2025 @ 12:57 AM
Gyre Therapeutics Announces Pricing of $20.0 Milli...
Source: N/A
Jun 18, 2024 @ 8:05 PM
Gyre Therapeutics Announces Publication in Journal...
Source: Gyre Therapeutics, Inc.
May 28, 2024 @ 8:05 PM
Gyre Therapeutics Announces Expected Addition to t...
Source: Gyre Therapeutics, Inc.
May 9, 2024 @ 8:10 PM
Gyre Therapeutics Reports First Quarter 2024 Finan...
Source: Gyre Therapeutics, Inc.
Financials
  TTM Q4 2024 FY 2024
Basic EPS $.03 $ $.14
Diluted EPS $ $ $.05
Revenue $ 22.06M $ 27.87M $ 105.76M
Gross Profit $ 21.16M $ 26.7M $ 101.87M
Net Income / Loss $ 3.73M $ .57M $ 17.9M
Operating Income / Loss $ 2.27M $ .6M $ 16.16M
Cost of Revenue $ .89M $ 1.18M $ 3.88M
Net Cash Flow $ 3.18M $ -3.8M $ -21.42M
PE Ratio    
Splits
Jan 13, 2023:   2:1
Feb 13, 2017:   1:15
Aug 21, 2015:   1:7